Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fluorination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel industrial route for 2,4,5-trifluorophenylacetic acid using 2,4-dichlorotoluene. High yield, cost-effective manufacturing for DPP-4 inhibitor intermediates.
Novel synthetic route for Favipiravir intermediate ensuring high yield and scalable production for global pharmaceutical supply chains and significant cost reduction.
Novel process for Favipiravir intermediate using microchannel technology reduces cost and enhances safety for reliable pharmaceutical intermediate supply chains.
Patent CN117843543A reveals a novel synthesis route for alpha alpha difluorobutyrolactam offering significant supply chain stability and cost reduction in fine chemical manufacturing.
Patent CN112142791A details enantioselective synthesis of alpha-fluoro-beta-carbonyl-diarylphosphine oxides using cinchona alkaloids for high-purity pharmaceutical intermediates.
Patent CN110028447A reveals a metal-free fluorination method offering high yield and purity. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118063317B reveals green route for ethyl 4,4-difluoroacetoacetate. Enhances supply chain reliability and cost reduction in agrochemical intermediate manufacturing.
Novel two-step route avoids liquid HF. High purity >99.9%. Cost-effective API intermediate manufacturing for antiviral drugs.
Novel two-step fluorination route for 5-fluorocytosine. High purity >99.9%, cost-effective, avoids HF. Ideal for API manufacturing.
Novel patent CN118894814B enables cost-effective synthesis of Factor XIa inhibitor intermediates with high purity and scalable supply chain reliability for global pharmaceutical manufacturing.
Patent CN101003530B details a robust synthesis for anticancer isoflavone derivatives. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN106083563A details a novel route for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN121270360A reveals efficient Pd NHC catalyzed synthesis enabling cost reduction and reliable supply chain for complex pharmaceutical intermediates manufacturing.
Patent CN102888227A discloses stable 1,1-difluorotetrahydronaphthalene compounds offering low threshold voltage and high charge retention for advanced TFT-LCD applications.
Patent CN106699710B details high negative dielectric anisotropy compounds. Enables cost reduction in electronic chemical manufacturing with scalable synthesis.
Patent CN113816882B details a novel one-pot dehydration method using Selectfluor and NaI, offering a safer, high-yield alternative to toxic POCl3 processes for pharmaceutical intermediates.
Advanced preparation method for metal difluorophosphate salts via mild fluorination. Enhances Li-ion battery cycle life. Reliable supplier for high-purity electrolyte additives.
Patent CN108276267B details a novel synthesis for fluorine-containing 1,1-stilbene derivatives. This route offers enhanced metabolic stability and scalable manufacturing for oncology drug development.
Patent CN102070497B reveals a novel four-step synthesis for florfenicol. This method offers mild conditions and high yields, ensuring cost reduction and supply chain reliability for global buyers.
Patent CN113402361A introduces a novel hypervalent iodine reagent for direct gem-difluorovinylation, offering streamlined synthesis and cost reduction in pharmaceutical intermediate manufacturing.